These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29969966)

  • 21. [Efficacy of combination of ondansetron injection and tablet in CAF-induced emesis in breast cancer patients].
    Shinohara H; Yonekawa H; Machimura T; Furukawa T; Nishihori H; Kurihara N; Urakami H; Nemoto Y
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):397-402. PubMed ID: 9492834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.
    Navari RM; Madajewicz S; Anderson N; Tchekmedyian NS; Whaley W; Garewal H; Beck TM; Chang AY; Greenberg B; Caldwell KC
    J Clin Oncol; 1995 Sep; 13(9):2408-16. PubMed ID: 7666101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ondansetron eliminates nausea and vomiting associated with prostacyclin in a patient awaiting lung transplantation.
    Lawhorn S; Lawhorn CD; Davison C
    J Heart Lung Transplant; 1997 Apr; 16(4):472-3. PubMed ID: 9154961
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ondansetron in the treatment of postoperative nausea and vomiting in ambulatory outpatients: a dose-comparative, stratified, multicentre study.
    Du Pen S; Scuderi P; Wetchler B; Sung YF; Mingus M; Clayborn L; Leslie J; Talke P; Apfelbaum J; Sharifi-Azad S
    Eur J Anaesthesiol Suppl; 1992 Nov; 6():55-62. PubMed ID: 1425626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ondansetron for symptomatic relief in terminal uraemia.
    Andrews PA; Quan V; Ogg CS
    Nephrol Dial Transplant; 1995; 10(1):140. PubMed ID: 7724017
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of intravenous and oral administration of ondansetron hydrochloride on chemotherapy-induced nausea and vomiting in patients with esophageal cancer].
    Miyashita M; Onda M; Ikeda K; Bando K; Hagiwara N; Tsuchiya Y; Yoshiyuki T; Kiyama T; Saito T; Sasajima K; Yamashita K
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1629-35. PubMed ID: 10553422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
    Tanimura S; Banba J; Tomoyasu H; Masaki M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined use of ondansetron and other anti-emetics to control cisplatin-induced nausea and vomiting].
    Zeng WY
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):118-21. PubMed ID: 8223120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and economic impact of oral ondansetron for vomiting in a pediatric emergency department.
    Hervás D; Armero C; Carrión T; Utrera JF; Hervás JA
    Pediatr Emerg Care; 2012 Nov; 28(11):1166-8. PubMed ID: 23114242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.
    Al Abood RM; Talegaonkar S; Tariq M; Ahmad FJ
    Colloids Surf B Biointerfaces; 2013 Jan; 101():143-51. PubMed ID: 22796784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ondansetron.
    Thavaraj V; Arya LS
    Indian Pediatr; 1995 Aug; 32(8):898-901. PubMed ID: 8635834
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of ondansetron for nausea and vomiting after head injury and its effect on return rates from the pediatric ED.
    Sturm JJ; Simon HK; Khan NS; Hirsh DA
    Am J Emerg Med; 2013 Jan; 31(1):166-72. PubMed ID: 23000332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.
    Tan J; Wang S; Liang X; Li CC; Zhang J; Zhao Z; Kong XR; Deng X; Peng L; Yang C
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28941006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial.
    Braude D; Crandall C
    Acad Emerg Med; 2008 Mar; 15(3):209-15. PubMed ID: 18304050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronological observation of nausea and vomiting in outpatients given oral antimetabolites as chemotherapy--two patients receiving ondansetron hydrochloride tablets].
    Sasaki K; Yanagida T; Ohya M; Ishikawa H
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):443-9. PubMed ID: 10740639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.